Our gratitude goes out to the individuals, families, and healthcare providers who participated in the clinical trial that led to the approval of TECENTRIQ as a first treatment for extensive-stage small cell lung cancer (ES-SCLC). Thank you for your courage in the fight against cancer.

Talking to your doctor about TECENTRIQ

Talk to your Doctor about TECENTRIQ (atezolizumab) for SCLC

Support and information

TECENTRIQ (atezolizumab) Support and Information

Financial assistance options

TECENTRIQ (atezolizumab) Financial Support

Information for caregivers

Information for caregivers